Asia Pacific Atopic Dermatitis Treatment Market By Treatment Type (Drug Treatment, Radiation Treatment), By Route Of Administration (Topical, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Asia Pacific Atopic Dermatitis Treatment Market By Treatment Type (Drug Treatment, Radiation Treatment), By Route Of Administration (Topical, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 5357 | Pages: 145 | December 2017 | Region: Asia Pacific


The Asia Pacific Atopic Dermatitis Treatment market size was around USD 1.81 billion in 2017. It is expected to grow at a CAGR of 13.8% to reach USD 3.45 billion by 2022. It captures 25% of the global market share.

Atopic Dermatitis is a inflammatory skin disease. The degree of its severity varies from patient to patient. It usually begins in childhood and is mostly confined to the flexural surfaces of the body. It is highly prevalent. It is more commonly known as eczema. Itching, redness of skin, cracking, weeping etc. are symptoms of it. It is a long term disease. Low humidity, cold weather, seasonal allergies are the common causes of it. Pattern of the disease and its severity determine the kind of treatment it ought to receive.

Growing patient population, a lot of new product launches, climate change, and large pipeline products are the primary drivers of market growth.

Very strict regulations and generic competition are the primary restraints of market growth.

The market is categorized by route of administration, treatment type, and by distribution channel. If we go by treatment type the market is segregated into Drug treatment and Radiation treatment. Drug treatment is further sub-categorized into corticosteroids, emollients, antihistamines, calcineurin inhibitors and antibiotics. Corticosteroids capture the largest market share and are expected to retain their lead till the end of 2022. Classification by Route of administration is done into topical and oral. Topical leads the market and is likely to retain its lead in the aforementioned forecast period. Oral medicines are for patients with severe cases. Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies is the classification based on the distribution channels.

By geography the market is segmented into India, China, Korea, Japan, and others. Asia Pacific is predicted to be the fastest growing market in the aforementioned forecast period. Rapidly growing population, changing lifestyles and a paradigm shift towards western lifestyles, increasing R&D, and large target patient pool are the reasons attributable to the observable trend mentioned above.

Key players in the market are Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment Type                       

                                5.1.1 Introduction           

                                5.1.2 Drug Treatment    

                                                5.1.2.1 Emollients

                                                5.1.2.2 Antihistamines

                                                5.1.2.3 Antibiotics

                                                5.1.2.4 Corticosteroids

                                                5.1.2.5 Calcineurin Inhibitors

                                5.1.3 Radiation Treatment           

                                5.1.4 Y-o-Y Growth Analysis, By Treatment Type               

                                5.1.5 Market Attractiveness Analysis, By Treatment Type             

                                5.1.6 Market Share Analysis, By Treatment Type              

                5.2 Route of administration                        

                                5.2.1 Introduction           

                                5.2.2 Topical      

                                5.2.3 Oral            

                                5.2.4 Y-o-Y Growth Analysis, By Route of administration               

                                5.2.5 Market Attractiveness Analysis, By Route of administration             

                                5.2.6 Market Share Analysis, By Route of administration               

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Retail Pharmacies 

                                5.3.4 Online Pharmacies               

                                5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.6 Market Attractiveness Analysis, By Distribution Channel    

                                5.3.7 Market Share Analysis, By Distribution Channel      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment Type

                                                6.1.3.3 By Route of administration

                                                6.1.3.4 By Distribution Channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment Type

                                                6.1.4.3 By Route of administration

                                                6.1.4.4 By Distribution Channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment Type

                                                6.1.5.3 By Route of administration

                                                6.1.5.4 By Distribution Channel

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Astellas Pharma Inc.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Sanofi S.A.                  

                8.3 Valeant Pharmaceuticals International, Inc.                 

                8.4 Novartis International AG                    

                8.5 Pfizer Inc.                    

                8.6 Meda Pharmaceuticals                          

                8.7 Regeneron Pharmaceuticals Inc.                       

                8.8 Anacor Pharmaceuticals, Inc.                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  •  Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Atopic Dermatitis Treatment Market By Treatment Type, From 2016-2022 ( USD Billion )
  2. Asia Pacific Drug Treatment Market By Region, From 2016-2022 ( USD Billion )
  3. Asia Pacific Radiation Treatment Market By Region, From 2016-2022 ( USD Billion )
  4. Asia Pacific Atopic Dermatitis Treatment Market By Route of Administration, From 2016-2022 ( USD Billion )
  5. Asia Pacific Topical Market By Region, From 2016-2022 ( USD Billion )
  6. Asia Pacific Oral Market By Region, From 2016-2022 ( USD Billion )
  7. Asia Pacific Atopic Dermatitis Treatment Market By Distribution Channel, From 2016-2022 ( USD Billion )
  8. Asia Pacific Hospital Pharmacies Market By Region, From 2016-2022 ( USD Billion )
  9. Asia Pacific Retail Pharmacies Market By Region, From 2016-2022 ( USD Billion )
  10. Asia Pacific Online Pharmacies Market By Region, From 2016-2022 ( USD Billion )
  11. Japan Atopic Dermatitis Treatment Market By Treatment Type, From 2016-2022 ( USD Billion )
  12. Japan Atopic Dermatitis Treatment Market By Route of Administration, From 2016-2022 ( USD Billion )
  13. Japan Atopic Dermatitis Treatment Market By Distribution Channel, From 2016-2022 ( USD Billion )
  14. China Atopic Dermatitis Treatment Market By Treatment Type, From 2016-2022 ( USD Billion )
  15. China Atopic Dermatitis Treatment Market By Route of Administration, From 2016-2022 ( USD Billion )
  16. China Atopic Dermatitis Treatment Market By Distribution Channel, From 2016-2022 ( USD Billion )
  17. India Atopic Dermatitis Treatment Market By Treatment Type, From 2016-2022 ( USD Billion )
  18. India Atopic Dermatitis Treatment Market By Route of Administration, From 2016-2022 ( USD Billion )
  19. India Atopic Dermatitis Treatment Market By Distribution Channel, From 2016-2022 ( USD Billion )
  20. Australia Atopic Dermatitis Treatment Market By Treatment Type, From 2016-2022 ( USD Billion )
  21. Australia Atopic Dermatitis Treatment Market By Route of Administration, From 2016-2022 ( USD Billion )
  22. Australia Atopic Dermatitis Treatment Market By Distribution Channel, From 2016-2022 ( USD Billion )
  23. South Korea Atopic Dermatitis Treatment Market By Treatment Type, From 2016-2022 ( USD Billion )
  24. South Korea Atopic Dermatitis Treatment Market By Route of Administration, From 2016-2022 ( USD Billion )
  25. South Korea Atopic Dermatitis Treatment Market By Distribution Channel, From 2016-2022 ( USD Billion )
Middle East And Africa Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Gr...
Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Asia Pacific Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tren...
Europe Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, An...
North America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region Global (Industry Analysis, Size, Share, Growth, Trends, An...
Middle East And Africa Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022...
Latin America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Asia Pacific Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Europe Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
North America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.